您的位置: 首页 > 农业专利 > 详情页

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES
专利权人:
THE MEDICAL COLLEGE OF WISCONSIN, INC.;WISCONSIN ALUMNI RESEARCH FOUNDATION
发明人:
Joseph T. Barbieri,Chen Chen,Amanda Przedpelski,Eric A. Johnson,Sabine Pellett
申请号:
US15509371
公开号:
US20170281737A1
申请日:
2015.09.29
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention provides a universal delivery platform of functional, heterologous compounds to specific cells using toxins modified to include a heterologous compound. In one embodiment, the toxin is an AB5 toxin. In one embodiment, the AB5 toxin is a heat-labile enterotoxin from E. coli (LT), including LTI, LTII, LTIIa, LTIIb, LTIIc and other recombinant forms of LT. Methods of use are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充